Genetic polymorphisms, biomarkers and signaling pathways associated with septic shock: from diagnosis to therapeutic targets

Abstract

Septic shock is a severe form of sepsis characterized by high global mortality rates and significant heritability. Clinicians have long been perplexed by the differential expression of genes, which poses challenges for early diagnosis and prompt treatment of septic shock. Genetic polymorphisms play crucial roles in determining susceptibility to, mortality from, and the prognosis of septic shock. Research indicates that pathogenic genes are known to cause septic shock through specific alleles, and protective genes have been shown to confer beneficial effects on affected individuals. Despite the existence of many biomarkers linked to septic shock, their clinical use remains limited. Therefore, further investigation is needed to identify specific biomarkers that can facilitate early prevention, diagnosis and risk stratification. Septic shock is closely associated with multiple signaling pathways, including the toll-like receptor 2/toll-like receptor 4, tumor necrosis factor-α, phosphatidylinositol 3-kinase/protein kinase B, mitogen-activated protein kinase, nuclear factor κB, Janus kinase/signal transducer and activator of transcription, mammalian target of rapamycin, NOD-like receptor thermal protein domain-associated protein 3 and hypoxia-induced-factor-1 pathways. Understanding the regulation of these signaling pathways may lead to the identification of therapeutic targets for the development of novel drugs to treat sepsis or septic shock. In conclusion, identifying differential gene expression during the development of septic shock allows physicians to stratify patients according to risk at an early stage. Furthermore, auxiliary examinations can assist physicians in identifying therapeutic targets within relevant signaling pathways, facilitating early diagnosis and treatment, reducing mortality and improving the prognosis of septic shock patients. Although there has been significant progress in studying the genetic polymorphisms, specific biomarkers and signaling pathways involved in septic shock, the journey toward their clinical application and widespread implementation still lies ahead.

Keywords

Septic shock / Sepsis / Gene polymorphism / Pathogenic gene / Biomarker / Signaling pathway

References

[1] Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, et al. The intensive care medicine research agenda on septic shock. Intens care med. 2017; 43: 1294-305.

[2] Vincent JL, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019; 23: 196.

[3] Liu YC, Yao Y, Yu MM, Gao YL, Qi AL, Jiang TY, et al. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis. BMC Infect Dis. 2022; 22: 564.

[4] Kadri SS, Rhee C, Strich JR, Morales MK, Hohmann S, Menchaca J, et al. Estimating ten-year trends in septic shock incidence and mortality in United States academic medical Centers using clinical data. Chest. 2017; 151: 278-85.

[5] Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Brit j anaesth. 2017; 119: 626-36.

[6] Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet resp med. 2018; 6: 40-50.

[7] Ling L, Joynt GM, Lipman J. A narrative review on antimicrobial therapy in septic shock: updates and controversies. Curr opin anesthesio. 2021; 34: 92-8.

[8] Arulappen AL, Danial M, Ng LW, Teoh JC. The impact of antibiotics administration on mortality for time in sepsis and septic shock patients including possible reasons for delayed Administration in Malaysia. Antibiotics (Basel). 2022; 11.

[9] Im Y, Kang D, Ko RE, Lee YJ, Lim SY, Park S, et al. Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. 2022; 26: 19.

[10] Wong HR. Clinical review: sepsis and septic shock-the potential of gene arrays. Crit Care. 2012; 16: 204.

[11] Wong HR. Genetics and genomics in pediatric septic shock. Crit Care Med. 2012; 40: 1618-26.

[12] Mohammed A, Cui Y, Mas VR, Kamaleswaran R. Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients. Sci Rep. 2019; 9: 11270.

[13] Kong C, Zhu Y, Xie X, Wu J, Qian M. Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study. Front Immunol. 2023; 14: 1184700.

[14] Grunwell JR, Weiss SL, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, et al. Differential expression of the Nrf2-linked genes in pediatric septic shock. Crit Care. 2015; 19: 327.

[15] Yang J, Zhang S, Zhang J, Dong J, Wu J, Zhang L, et al. Identification of key genes and pathways using bioinformatics analysis in septic shock children. Infect Drug Resist. 2018; 11: 1163-74.

[16] Long G, Yang C. A six-gene support vector machine classifier contributes to the diagnosis of pediatric septic shock. Mol Med Rep. 2020; 21: 1561-71.

[17] Hu Y, Cheng L, Zhong W, Chen M, Zhang Q. Bioinformatics analysis of gene expression profiles for risk prediction in patients with septic shock. Med Sci Monit. 2019; 25: 9563-71.

[18] Wang Q, Huang J, Chen X, Wang J, Fang F. Transcriptomic markers in pediatric septic shock prognosis: an integrative analysis of gene expression profiles. Braz J Med Biol Res. 2021; 54: e10152.

[19] Zeng X, Feng J, Yang Y, Zhao R, Yu Q, Qin H, et al. Screening of key genes of sepsis and septic shock using bioinformatics analysis. J Inflamm Res. 2021; 14: 829-41.

[20] Yu N, Liu X, Shi D, Bai L, Niu T, Liu Y. CD63 and C3AR1: the potential molecular targets in the progression of septic shock. Int J Gen Med. 2022;Volume 15: 711-28.

[21] Shi S, Pan X, Feng H, Zhang S, Shi S, Lin W. Identification of transcriptomics biomarkers for the early prediction of the prognosis of septic shock from pneumopathies. BMC Infect Dis. 2021; 21: 1190.

[22] Tang Y, Yang X, Shu H, Yu Y, Pan S, Xu J, et al. Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury. Hereditas. 2021; 158: 13.

[23] Niu J, Qin B, Wang C, Chen C, Yang J, Shao H. Identification of key immune-related genes in the progression of septic shock. Front Genet. 2021; 12: 668527.

[24] Xu Z, Jiang M, Bai X, Ding L, Dong P, Jiang M. Identification and verification of potential Core genes in Pediatric septic shock. Comb chem high t scr. 2022; 25: 2228-39.

[25] Jiang Y, Miao Q, Hu L, Zhou T, Hu Y, Tian Y. FYN and CD247: key genes for septic shock based on bioinformatics and meta-analysis. Comb chem high t scr. 2022; 25: 1722-30.

[26] Fan Y, Han Q, Li J, Ye G, Zhang X, Xu T, et al. Revealing potential diagnostic gene biomarkers of septic shock based on machine learning analysis. BMC Infect Dis. 2022; 22: 65.

[27] Zhao S, Zhu K, Li X, Zhong X, Zhao Y, le Z, et al. Co-expression and interaction network analysis reveals dysregulated neutrophil and T-cell activation as the core mechanism associated with septic shock. Front Genet. 2023; 14: 1132361.

[28] Wang J, Cai J, Yue L, Zhou X, Hu C, Zhu H. Identification of potential biomarkers of septic shock based on pathway and transcriptome analyses of immune-related genes. Genet Res. 2023; 2023: 1-19.

[29] Yang Q, Feng Z, Ding D, Kang C. CD3D and CD247 are the molecular targets of septic shock. Medicine. 2023; 102: e34295.

[30] Czerska K, Nawara M, Bal J, Bal JI. Single nucleotide polymorphism in human genetic analyses. Med Wieku Rozwoj. 2003; 7: 531-46.

[31] Kumar A, Short J, Parrillo JE. Genetic factors in septic shock. Jama-j am med assoc. 1999; 282: 579-81.

[32] He J, Zhang Q, Zhang W, Chen F, Zhao T, Lin Y, et al. The interleukin-27-964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis. Crit Care. 2018; 22: 248.

[33] Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med. 2000; 28: 2733-6.

[34] Küçükaycan M, Van Krugten M, Pennings HJ, Huizinga TW, Buurman WA, Dentener MA, et al. Tumor necrosis factor-alpha +489G/a gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res. 2002; 3: 29.

[35] Al-Amodi HS, Abdelsattar S, Kasemy ZA, Bedair HM, Elbarbary HS, Kamel HFM. Potential value of TNF-α (−376 G/a) polymorphism and cystatin C (CysC) in the diagnosis of sepsis associated acute kidney injury (S-AK I) and prediction of mortality in critically ill patients. Front Mol Biosci. 2021; 8: 751299.

[36] Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest. 2003; 124: 1103-15.

[37] Behairy MY, Abdelrahman AA, Toraih EA, Ibrahim EEA, Azab MM, Sayed AA, et al. Investigation of TLR2 and TLR4 polymorphisms and sepsis susceptibility: computational and experimental approaches. Int J Mol Sci. 2022; 23:null.

[38] Nakada TA, Boyd JH, Russell JA, Aguirre-Hernández R, Wilkinson MD, Thair SA, et al. VPS13D gene variant is associated with altered IL-6 production and mortality in septic shock. J innate immun. 2015; 7: 545-53.

[39] Zhang DL, Zheng HM, Yu BJ, Jiang ZW, Li JS. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World j gastroentero. 2005; 11: 4409-13.

[40] Nakada TA, Wacharasint P, Russell JA, Boyd JH, Nakada E, Thair SA, et al. The IL20 genetic polymorphism is associated with altered clinical outcome in septic shock. J innate immun. 2018; 10: 181-8.

[41] Zapata-Tarrés M, Arredondo-García JL, Rivera-Luna R, Klünder-Klünder M, Mancilla-Ramírez J, Sánchez-Urbina R, et al. Interleukin-1 receptor antagonist gene polymorphism increases susceptibility to septic shock in children with acute lymphoblastic leukemia. Pediatr Infect Dis J. 2013; 32: 136-9.

[42] Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L.Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med. 2002; 30: 969-73.

[43] Madách K, Aladzsity I, Szilágyi A, Fust G, Gál J, Pénzes I, et al. 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care. 2010; 14: R79.

[44] Cogulu O, Onay H, Uzunkaya D, Gunduz C, Pehlivan S, Vardar F, et al. Role of angiotensin-converting enzyme gene polymorphisms in children with sepsis and septic shock. Pediatr Int. 2008; 50: 477-80.

[45] Nakada TA, Russell JA, Boyd JH, McLaughlin L, Nakada E, Thair SA, et al. Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med. 2011; 39: 1641-8.

[46] Nakada TA, Russell JA, Boyd JH, Aguirre-Hernandez R, Thain KR, Thair SA, et al. beta2-adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am j resp crit care. 2010; 181: 143-9.

[47] Graebin P, Veit TD, Alho CS, Dias FS, Chies JA. Polymorphic variants in exon 8 at the 3’ UTR of the HLA-G gene are associated with septic shock in critically ill patients. Crit Care. 2012; 16: R211.

[48] Toubiana J, Courtine E, Pène F, Viallon V, Asfar P, Daubin C, et al. IRAK1 functional genetic variant affects severity of septic shock. Crit Care Med. 2010; 38: 2287-94.

[49] Peng LS, Li J, Zhou GS, Deng LH, Yao HG. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and septic shock in a Chinese Han population. World J Emerg Med. 2015; 6: 123-30.

[50] Pérez-García F, Jiménez-Sousa M, Gómez-Sánchez E, Gonzalo-Benito H, Fernández-Rodríguez A, Lorenzo-López M, et al. CEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patients. J microbiol immunol. 2022; 55: 540-4.

[51] O’Dwyer MJ, Dempsey F, Crowley V, Kelleher DP, McManus R, Ryan T. Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit Care. 2006; 10: R139.

[52] Rosier F, Brisebarre A, Dupuis C, Baaklini S, Puthier D, Brun C, et al. Genetic predisposition to the mortality in septic shock patients: from GWAS to the identification of a regulatory variant modulating the activity of a CISH enhancer. Int J Mol Sci. 2021; 22.

[53] Li J, Zhou H, Wei B, Che D, Xu Y, Pi L, et al. The rs8506 TT genotype in lincRNA-NR_024015 contributes to the risk of sepsis in a southern Chinese child population. Front Public Health. 2022; 10: 927527.

[54] Nakada TA, Russell JA, Boyd JH, Thair SA, Walley KR. Identification of a nonsynonymous polymorphism in the SVEP1 gene associated with altered clinical outcomes in septic shock. Crit Care Med. 2015; 43: 101-8.

[55] Sun W, Li FS, Zhang YH, Wang XP, Wang CR. Association of susceptibility to septic shock with platelet endothelial cell adhesion molecule-1 gene Leu125Val polymorphism and serum sPECAM-1 levels in sepsis patients. Int J Clin Exp Med. 2015; 8: 20490- 8.

[56] Paludo FJ, Picanço JB, Fallavena PR, Fraga LR, Graebin P, Nóbrega OT, et al. Higher frequency of septic shock in septic patients with the 47C allele (rs4880) of the SOD2 gene. Gene. 2013; 517: 106-11.

[57] Nakada TA, Russell JA, Wellman H, Boyd JH, Nakada E, Thain KR, et al. Leucyl/cystinyl aminopeptidase gene variants in septic shock. Chest. 2011; 139: 1042-9.

[58] Vilander LM, Kaunisto MA, Vaara ST, Pettilä V. Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock. Crit Care. 2017; 21: 47.

[59] Cui L, Gao Y, Xie Y, Wang Y, Cai Y, Shao X, et al. An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis. Crit Care. 2015; 19: 73.

[60] Temple SE, Cheong KY, Ardlie KG, Sayer D, Waterer GW. The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. Intens care med. 2004; 30: 1761-7.

[61] Clavier T, Grangé S, Pressat-Laffouilhere T, Besnier E, Renet S, Fraineau S, et al. Gene expression of protein tyrosine phosphatase 1B and endoplasmic reticulum stress during septic shock. Front Med (Lausanne). 2019; 6: 240.

[62] Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care. 2010; 14: R133.

[63] Hara T, Mimura K, Abe T, Shioi G, Seiki M, Sakamoto T. Deletion of the Mint3/Apba3 gene in mice abrogates macrophage functions and increases resistance to lipopolysaccharide-induced septic shock. J Biol Chem. 2011; 286: 32542-51.

[64] Wang SS, Yan CS, Luo JM. NLRC4 gene silencing-dependent blockade of NOD-like receptor pathway inhibits inflammation, reduces proliferation and increases apoptosis of dendritic cells in mice with septic shock. Aging (Albany NY). 2021; 13: 1440-57.

[65] Georgescu AM, Banescu C, Azamfirei R, Hutanu A, Moldovan V, Badea I, et al. Evaluation of TNF-α genetic polymorphisms as predictors for sepsis susceptibility and progression. BMC Infect Dis. 2020; 20: 221.

[66] Ferwerda B, Alonso S, Banahan K, McCall MB, Giamarellos-Bourboulis EJ, Ramakers BP, et al. Functional and genetic evidence that the mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. P natl acad sci USA. 2009; 106: 10272-7.

[67] Meyer NJ, Ferguson JF, Feng R, Wang F, Patel PN, Li M, et al. A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am j resp crit care. 2014; 190: 656-64.

[68] Pérez-García F, Resino S, Gómez-Sánchez E, Gonzalo-Benito H, Fernández-Rodríguez A, Lorenzo-López M, et al. OLFM4 polymorphisms predict septic shock survival after major surgery. Eur J Clin Investig. 2021; 51: e13416.

[69] Xu M, Shao Y, Lin K, Liu Y, Lin Y, Lin Y, et al. Genetic Arg-304-his substitution in GRK5 protects against sepsis progression by alleviating NF-κB-mediated inflammation. Int Immunopharmacol. 2023; 115: 109629.

[70] Cohen J, Blumenthal A, Cuellar-Partida G, Evans DM, Finfer S, Li Q, et al. The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock. Intens care med. 2021; 47: 974-83.

[71] Kim SJ, Hwang SO, Kim YW, Lee JH, Cha KC. Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on Sepsis-3 definition. Am J Emerg Med. 2019; 37: 272-6.

[72] Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Improved risk stratification in Pediatric septic shock using both protein and mRNA biomarkers. PERSEVERE-XP Am j resp crit care. 2017; 196: 494-501.

[73] Wong HR, Lindsell CJ, Pettilä V, Meyer NJ, Thair SA, Karlsson S, et al. A multibiomarker-based outcome risk stratification model for adult septic shock^*. Crit Care Med. 2014; 42: 781-9.

[74] Kothari N, Bogra J, Abbas H, Kohli M, Malik A, Kothari D, et al. Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock. Cytokine. 2013; 61: 676-81.

[75] O’Dwyer MJ, Mankan AK, Stordeur P, O’Connell B, Duggan E, White M, et al. The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock. 2006; 26: 544-50.

[76] Park JH, Shin SH. Induction of IL-12 gene expression in the brain in septic shock. Biochem bioph res co. 1996; 224: 391-6.

[77] Macdonald SP, Stone SF, Neil CL, van Eeden PE, Fatovich DM, Arendts G, et al. Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department. PLoS One. 2014; 9: e110678.

[78] Leśnik P, Janc J, Mierzchala-Pasierb M, Tański W, Wierciński J, Łysenko L. Interleukin-7 and interleukin-15 as prognostic biomarkers in sepsis and septic shock: correlation with inflammatory markers and mortality. Cytokine, 156277. 2023; 169: 156277.

[79] Cauvi DM, Williams MR, Bermudez JA, Armijo G, De Maio A. Elevated expression of IL-23/IL-17 pathway-related mediators correlates with exacerbation of pulmonary inflammation during polymicrobial sepsis. Shock. 2014; 42: 246-55.

[80] Tomala J, Weberova P, Tomalova B, Jiraskova Zakostelska Z, Sivak L, Kovarova J, et al. IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25+Foxp3-T cells. elife. 2021; 10:null.

[81] Turan YB. The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock. BMC Anesthesiol. 2023; 23: 278.

[82] Payen D, Lukaszewicz AC, Belikova I, Faivre V, Gelin C, Russwurm S, et al. Gene profiling in human blood leucocytes during recovery from septic shock. Intens care med. 2008; 34: 1371-6.

[83] Demaret J, Villars-Méchin A, Lepape A, Plassais J, Vallin H, Malcus C, et al. Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients. Intens care med. 2014; 40: 1089-96.

[84] Baranowsky A, Appelt J, Kleber C, Lange T, Ludewig P, Jahn D, et al. Procalcitonin exerts a mediator role in septic shock through the calcitonin gene-related peptide receptor. Crit Care Med. 2021; 49: e41-52.

[85] D’Urso S, Rajbhandari D, Peach E, de Guzman E, Li Q, Medland SE, et al. Septic shock: a Genomewide association study and polygenic risk score analysis. Twin res hum genet. 2020; 23: 204-13.

[86] Martínez-Paz P, Aragón-Camino M, Gómez-Sánchez E, Lorenzo-López M, Gómez-Pesquera E, Fadrique-Fuentes A, et al. Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression. J Inf Secur. 2021; 83: 147-55.

[87] Liu X, Xu Q, Mei L, Lei H, Wen Q, Miao J, et al. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats. Int Immunopharmacol. 2018; 61: 169-77.

[88] Lu J, Liu J, Li A. Roles of neutrophil reactive oxygen species (ROS) generation in organ function impairment in sepsis. J zhejiang univ-sc b. 2022; 23: 437-50.

[89] Tian R, Wang X, Pan T, Li R, Wang J, Liu Z, et al. Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock. Scand J Immunol. 2019; 90: e12823.

[90] François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, et al. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. Lancet resp med. 2023; 11: 894-904.

[91] Arnalich F, Hernanz A, Jiménez M, López J, Tato E, Vázquez JJ, et al. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul peptides. 1996; 65: 115-21.

[92] Yu MH, Chen MH, Han F, Li Q, Sun RH, Tu YX. Prognostic value of the biomarkers serum amyloid a and nitric oxide in patients with sepsis. Int Immunopharmacol. 2018; 62: 287-92.

[93] Whitney JE, Silverman M, Norton JS, Bachur RG, Melendez E. Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor as novel biomarkers for poor outcomes in children with severe sepsis and septic shock. Pediatr Emerg Care. 2020; 36: e715-9.

[94] Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, Allen GL, et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics. 2007; 30: 146-55.

[95] Busani S, De Biasi S, Nasi M, Paolini A, Venturelli S, Tosi M, et al. Increased plasma levels of mitochondrial DNA and normal Inflammasome gene expression in monocytes characterize patients with septic shock due to multidrug resistant bacteria. Front Immunol. 2020; 11: 768.

[96] Andaluz-Ojeda D, Nguyen HB, Meunier-Beillard N, Cicuéndez R, Quenot JP, Calvo D, et al. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Ann Intensive Care. 2017; 7: 15.

[97] Molinari L, Heskia F, Peerapornratana S, Ronco C, Guzzi L, Toback S, et al. Limiting acute kidney injury progression in sepsis: study protocol and trial simulation. Crit Care Med. 2021; 49: 1706-16.

[98] Liu Y, Yin H, Zhao M, Lu Q. TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin rev allerg immu. 2014; 47: 136-47.

[99] Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11: 443-51.

[100] Sato S, Nomura F, Kawai T, Takeuchi O, Mühlradt PF, Takeda K, et al. Synergy and cross-tolerance between toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J Immunol. 2000; 165: 7096-101.

[101] Du B, Luo W, Li R, Tan B, Han H, Lu X, et al. Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression. J Biol Chem. 2013; 288: 15131-41.

[102] Couture LA, Piao W, Ru LW, Vogel SN, Toshchakov VY. Targeting toll-like receptor (TLR) signaling by toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/mal)-derived decoy peptides. J Biol Chem. 2012; 287: 24641-8.

[103] Jakka P, Bhargavi B, Namani S, Murugan S, Splitter G, Radhakrishnan G. Cytoplasmic linker protein CLIP170 negatively regulates TLR4 Signaling by targeting the TLR adaptor protein TIRAP. J Immunol. 2018; 200: 704-14.

[104] Calandra T.Pathogenesis of septic shock: implications for prevention and treatment. J chemotherapy. 2001; 13: 173-80.

[105] Graveline R, Segura M, Radzioch D, Gottschalk M. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int Immunol. 2007; 19: 375-89.

[106] Majewska M, Szczepanik M. The role of toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation. Postepy Hig Med Dosw (Online). 2006; 60: 52-63.

[107] Piao W, Ru LW, Toshchakov VY. Differential adapter recruitment by TLR2 co-receptors. Pathog Dis. 2016;74null: ftw043.

[108] Tsan MF, Gao B. Endogenous ligands of toll-like receptors. J Leukoc Biol. 2016; 76: 514-9.

[109] Oblak A, Jerala R. The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex. Mol Immunol. 2015; 63: 134-42.

[110] Lendak DF, Mihajlović DM, Novakov-Mikić AS, Mitić IM, Boban JM, Brkić SV. The role of TNF-α superfamily members in immunopathogenesis of sepsis. Cytokine. 2018; 111: 125-30.

[111] Li C, Gu H, Yu M, Yang P, Zhang M, Ba H, et al. Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock. Cell Death Dis. 2019; 10: 586.

[112] Kurmyshkina OV, Bogdanova AA, Volkova TO, Poltoraka AN. Septic shock: innate molecular genetic mechanisms of the development of generalized inflammation. Ontogenez. 2015; 46: 225-39.

[113] Aggarwal BB. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis. JNK and NF-kappaB Ann rheum dis. 2000; 59: 6i-16.

[114] Yan J, Zhang H, Xiang J, Zhao Y, Yuan X, Sun B, et al. The BH3-only protein BAD mediates TNF α cytotoxicity despite concurrent activation of IKK and NF-κB in septic shock. Cell Res. 2018; 28: 701-18.

[115] Brown MA, Jones WK. NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci. 2004; 9: 1201-17.

[116] Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013; 12: 86.

[117] Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G. NF-κB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022; 43: 757-75.

[118] Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat rev immunol. 2018; 18: 309-24.

[119] Wang J, Wang X, Hussain S, Zheng Y, Sanjabi S, Ouaaz F, et al. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J Immunol. 2007; 178: 6777-88.

[120] Jiang Y, Gong XW. Regulation of inflammatory responses by MAPK signal transduction pathways. Sheng Li Xue Bao. 2000; 52: 267-71.

[121] Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol. 2005; 6: 587-92.

[122] Miller MR, Koch SR, Choi H, Lamb FS, Stark RJ. Apoptosis signal-regulating kinase 1 (ASK1) inhibition reduces endothelial cytokine production without improving permeability after toll-like receptor 4 (TLR4) challenge. Transl Res. 2021; 235: 115-28.

[123] Shin JN, Rao L, Sha Y, Abdel Fattah E, Hyser J, Eissa NT. p38 MAPK activity is required to prevent Hyperactivation of NLRP3 Inflammasome. J Immunol. 2021; 207: 661-70.

[124] Dong R, Xue Z, Fan G, Zhang N, Wang C, Li G, et al. Pin1 promotes NLRP3 Inflammasome activation by phosphorylation of p38 MAPK pathway in septic shock. Front Immunol. 2021; 12: 620238.

[125] Cai B, Cai JP, Luo YL, Chen C, Zhang S. The specific roles of JAK/STAT Signaling pathway in sepsis. Inflammation. 2015; 38: 1599-608.

[126] Purohit M, Gupta G, Afzal O, Altamimi ASA, Alzarea SI, Kazmi I, et al. Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in lung inflammatory disease. Chem Biol Interact. 2023; 371: 110334.

[127] Clere-Jehl R, Mariotte A, Meziani F, Bahram S, Georgel P, Helms J. JAK-STAT targeting offers novel therapeutic opportunities in sepsis. Trends Mol Med. 2020; 26: 987-1002.

[128] Samavati L, Rastogi R, Du W, Hüttemann M, Fite A, Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol. 2009; 46: 1867-77.

[129] Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9: 798-809.

[130] Very N, Vercoutter-Edouart AS, Lefebvre T, Hardivillé S, El Yazidi-Belkoura I. Cross-dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR Axis in human chronic diseases. Front Endocrinol (Lausanne). 2018; 9: 602.

[131] Tang G, Yang H, Chen J, Shi M, Ge L, Ge X, et al. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway. Oncotarget. 2017; 8: 97977-89.

[132] Guo W, Hu Z. SRPK1 promotes sepsis-induced acute lung injury via regulating PI3K/AKT/FOXO3 signaling. Immunopharm immunot. 2023; 45: 203-12.

[133] Li M, Ye J, Zhao G, Hong G, Hu X, Cao K, et al. Gas6 attenuates lipopolysaccharide-induced TNF-α expression and apoptosis in H9C2 cells through NF-κB and MAPK inhibition via the Axl/PI3K/Akt pathway. Int J Mol Med. 2019; 44: 982-94.

[134] Pan T, Sun S, Chen Y, Tian R, Chen E, Tan R, et al. Immune effects of PI3K/Akt/HIF-1α-regulated glycolysis in polymorphonuclear neutrophils during sepsis. Crit Care. 2022; 26: 29.

[135] Shang X, Lin K, Yu R, Zhu P, Zhang Y, Wang L, et al. Resveratrol protects the myocardium in sepsis by activating the phosphatidylinositol 3-kinases (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway and inhibiting the nuclear factor-κB (NF-κB) Signaling pathway. Med Sci Monit. 2019; 25: 9290-8.

[136] Sun B, Xiao J, Sun XB, Wu Y. Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling. Brit j pharmacol. 2013; 168: 1758-70.

[137] Mao L, Lin W, Nie T, Hui X, Gao X, Li K, et al. Absence of Appl2 sensitizes endotoxin shock through activation of PI3K/Akt pathway. Cell Biosci. 2014; 4: 60.

[138] Hou Y, Liang Z, Qi L, Tang C, Liu X, Tang J, et al. Baicalin targets HSP70/90 to regulate PKR/PI3K/AKT/eNOS Signaling pathways. Molecules. 2022; 27.

[139] Wang H, Zhu J, Wei L, Wu S, Shang L, Ye X, et al. TSLP protects against sepsis-induced liver injury by inducing autophagy via activation of the PI3K/Akt/STAT3 pathway. Pathol Res Pract. 2022; 236: 153979.

[140] Lee KH, Jeong J, Yoo CG. Positive feedback regulation of heat shock protein 70 (Hsp70) is mediated through toll-like receptor 4-PI3K/Akt-glycogen synthase kinase-3β pathway. Exp Cell Res. 2013; 319: 88-95.

[141] You W, Min X, Zhang X, Qian B, Pang S, Ding Z, et al. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism. Shock. 2009; 32: 108-17.

[142] Liu L, Yan M, Yang R, Qin X, Chen L, Li L, et al. Adiponectin attenuates lipopolysaccharide-induced apoptosis by regulating the Cx43/PI3K/AKT pathway. Front Pharmacol. 2021; 12: 644225.

[143] Ha T, Lu C, Liu L, Hua F, Hu Y, Kelley J, et al. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. Am j physiol-heart c. 2010; 298: H984-91.

[144] Soltani A, Bahreyni A, Boroumand N, Roshan MK, Khazaee M, Ryzhikov M, et al. Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives. J Cell Physiol. 2018; 233: 4783-90.

[145] Bai G, Wang H, Cui N. mTOR pathway mediates endoplasmic reticulum stress-induced CD4+ T cell apoptosis in septic mice. Apoptosis. 2022; 27: 740-50.

[146] Liu MX, Yang J, Qin Y, Li ZD, Jin J, Zhang YB, et al. ESMOLOL PROTECTS AGAINST LPS-INDUCED CARDIAC INJURY VIA THE AMPK/mTOR/ULK1 PATHWAY IN RAT. Shock. 2023; 59: 469-76.

[147] Wang Y, Luan C, Zhang G, Sun C. The transcription factor cMaf is targeted by mTOR, and regulates the inflammatory response via the TLR4 signaling pathway. Int J Mol Med. 2018; 41: 2935-42.

[148] Ibañez-Cabellos JS, Aguado C, Pérez-Cremades D, García-Giménez JL, Bueno-Betí C, García-López EM, et al. Extracellular histones activate autophagy and apoptosis via mTOR signaling in human endothelial cells. Bba-mol basis dis. 2018; 1864: 3234-46.

[149] Zhang T, Lu X, Li J, Chidiac P, Sims SM, Feng Q. Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/mTOR signaling in endotoxemia. Basic Res Cardiol. 2012; 107: 254.

[150] He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 Inflammasome activation. Trends Biochem Sci. 2016; 41: 1012-21.

[151] Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X, et al. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J Neuroinflammation. 2021; 18: 123.

[152] Huang W, Wang X, Xie F, Zhang H, Liu D. Serum NLRP3: a biomarker for identifying high-risk septic patients. Cytokine. 2022; 149: 155725.

[153] Singh N, Sharma G, Mishra V, Raghubir R. Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol. 2012; 32: 491-507.

[154] Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005; 365: 871-5.

[155] Sakamoto T, Seiki M. Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1. J Biol Chem. 2009; 284: 30350-9.

[156] Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm (Lond). 2020; 17: 33.

[157] Brigati C, Banelli B, di Vinci A, Casciano I, Allemanni G, Forlani A, et al. Inflammation, HIF-1, and the epigenetics that follows. Mediat Inflamm. 2010; 2010: 263914, 1- 5.

[158] Hierholzer C, Harbrecht BG, Billiar TR, Tweardy DJ. Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock. Arch orthop traum su. 2001; 121: 219-22.

[159] Lou X, Xue J, Shao R, Mo C, Wang F, Chen G. Postbiotics as potential new therapeutic agents for sepsis. Burns Trauma. 2023; 11: tkad022.

[160] Zhao PY, Yao RQ, Zheng LY, Wu Y, Li YX, Dong N, et al. Nuclear fragile X mental retardation-interacting protein 1-mediated ribophagy protects T lymphocytes against apoptosis in sepsis. Burns Trauma. 2023; 11: tkac055.